文献速递糖尿病

糖化作用降低饮食控制的2型糖尿病患者ApoAI稳定性并加重HDL功能障碍

Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

研究采用2H2O代谢标记法,比较饮食控制的2型糖尿病患者(n=9)与匹配健康对照(n=8)的ApoAI周转,发现患者ApoAI周转增加、HDL胆固醇外流和抗氧化功能受损;糖化血红蛋白与ApoAI半衰期及HDL胆固醇外流功能负相关,蛋白质组学鉴定ApoAI赖氨酸位点Amadori糖化,糖化使ApoAI半衰期缩短三倍。

要点

  • 饮食控制的2型糖尿病患者ApoAI周转增加,HDL胆固醇外流和抗氧化功能受损。
  • 糖化血红蛋白与ApoAI半衰期及HDL胆固醇外流功能呈负相关。
  • ApoAI赖氨酸位点发生Amadori糖化,糖化使ApoAI半衰期缩短三倍。

核心结论

  • 2H2O方法可检测2型糖尿病患者HDL代谢和功能的早期体内损伤,这些损伤与高血糖诱导的ApoAI糖化相关。

研究设计与样本

  • 采用2H2O代谢标记方法研究饮食控制的2型糖尿病患者(n=9,女性5例,年龄59.3±8.5岁)与匹配健康对照(n=8,女性4例,年龄50.7±11.6岁)的ApoAI周转。
  • 采用蛋白质组学方法和体外试验评估Amadori糖化对ApoAI体内稳定性的影响以及HDL的抗氧化和胆固醇外流特性。

主要发现

  • 2型糖尿病患者ApoAI周转增加,HDL胆固醇外流和抗氧化特性受损。
  • 糖化血红蛋白与ApoAI半衰期及HDL胆固醇外流功能呈负相关。
  • 蛋白质组学分析鉴定出ApoAI多个赖氨酸位点的非酶早期(Amadori)糖化。
  • 对2型糖尿病患者糖化和天然ApoAI肽段的动力学分析显示,糖化导致ApoAI半衰期缩短三倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Hyperglycemia plays a key role in the pathogenesis of cardiovascular complications of diabetes. Type 2 diabetes mellitus (T2DM) is associated with high-density lipoprotein (HDL) dysfunction and increased degradation of apolipoprotein I (ApoAI). The mechanism(s) of these changes is largely unknown. OBJECTIVE: To study the role of hyperglycemia-induced glycation on ApoAI kinetics and stability in patients with diet-controlled T2DM. DESIGN: 2H2O-metabolic labeling approach was used to study ApoAI turnover in patients with diet-controlled T2DM [n = 9 (5 F); 59.3 ± 8.5 years] and matched healthy controls [n = 8 (4 F); 50.7 ± 11.6 years]. The effect of Amadori glycation on in vivo ApoAI stability and the antioxidant and cholesterol efflux properties of HDL were assessed using a proteomics approach and in vitro assays. RESULTS: Patients with T2DM had increased turnover of ApoAI and impaired cholesterol efflux and antioxidant properties of HDL. Glycated hemoglobin was negatively correlated with the half-life of ApoAI and cholesterol efflux function of HDL. Proteomics analysis identified several nonenzymatic early (Amadori) glycations of ApoAI at lysine sites. The kinetics analysis of glycated and native ApoAI peptides in patients with T2DM revealed that glycation resulted in a threefold shorter ApoAI half-life. CONCLUSIONS: The 2H2O method allowed the detection of early in vivo impairments in HDL metabolism and function that were related to hyperglycemia-induced glycation of ApoAI in T2DM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kashyap SR, Osme A, Ilchenko S, et al. Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes. J Clin Endocrinol Metab. 2018. PMID: 29077935. doi:10.1210/jc.2017-01551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。